Next Article in Journal
Integrated Exhaled VOC and Clinical Biomarker Profiling for Predicting Bronchodilator Responsiveness in Asthma and COPD Patients
Previous Article in Journal
Effect of Cataracts on Hydroxychloroquine Retinopathy Screening
Previous Article in Special Issue
Squamous Metaplasia of Lactiferous Ducts (SMOLD) in a Male Patient: Clinical, Dermoscopic, and Histopathological Insights
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Multiple, Segmental, Non-Syndromic Basal Cell Carcinomas—Clinical, Dermoscopic and Histopathological Features †

by
Martyna Sławińska
1,*,
Beata Zagórska
1,
Wojciech Biernat
2 and
Michał Sobjanek
1
1
Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdańsk, 80-214 Gdańsk, Poland
2
Department of Pathomorphology, Faculty of Medicine, Medical University of Gdańsk, 80-214 Gdańsk, Poland
*
Author to whom correspondence should be addressed.
Prior presentation: This Interesting Image has been previously reported as e-poster during 29th EADV Congress.
Diagnostics 2025, 15(21), 2739; https://doi.org/10.3390/diagnostics15212739
Submission received: 12 July 2025 / Revised: 17 October 2025 / Accepted: 26 October 2025 / Published: 28 October 2025
(This article belongs to the Special Issue Advances in Diagnosis and Management of Skin Diseases)

Abstract

We present a case of a 72-year-old woman with four amelanotic tumors on the left arm, without a history of skin cancer or sun exposure. Dermoscopy showed polymorphic and arborizing vessels, with some lesions displaying non-specific malignant features. Histopathology confirmed basal cell carcinoma (BCC) in all lesions. No signs of recurrence were observed during 3-year follow-up. Segmental/agminated basal cell carcinoma is a rare differential diagnosis of multiple clustered, painless pink tumors. To the best of our knowledge, this is the first report describing their dermoscopic features.

Figure 1. A 72-year-old woman (phototype II) presented with four amelanotic tumors on the left arm (A). The lesions developed on the skin area, without signs of photodamage. There was no personal or family history of skin cancer. In addition, she reported no comorbidities, excessive UV exposure, or contact with potentially cancerogenic chemicals. The largest lesion appeared around 12 months before, and the smaller ones several months prior to hospital admission. Clinical assessment did not show typical abnormalities for genetic syndromes associated with multiple BCC. Dermoscopy of the largest tumor showed polymorphic vessels over yellow-pinkish background (B); the smaller lesions revealed the presence of an ulceration and/or arborizing vessels (CE). Dermoscopic features of this entity have not been previously reported, but it seems to share features observed in the BCC spectrum [1]. While the arborizing (branched) vessels in one of the tumors (E) could serve as a diagnostic clue, the remaining lesions presented non-characteristic patterns—yellow structureless areas corresponding to the ulceration or polymorphic vascular pattern, known as non-specific sign of malignancy.
Figure 1. A 72-year-old woman (phototype II) presented with four amelanotic tumors on the left arm (A). The lesions developed on the skin area, without signs of photodamage. There was no personal or family history of skin cancer. In addition, she reported no comorbidities, excessive UV exposure, or contact with potentially cancerogenic chemicals. The largest lesion appeared around 12 months before, and the smaller ones several months prior to hospital admission. Clinical assessment did not show typical abnormalities for genetic syndromes associated with multiple BCC. Dermoscopy of the largest tumor showed polymorphic vessels over yellow-pinkish background (B); the smaller lesions revealed the presence of an ulceration and/or arborizing vessels (CE). Dermoscopic features of this entity have not been previously reported, but it seems to share features observed in the BCC spectrum [1]. While the arborizing (branched) vessels in one of the tumors (E) could serve as a diagnostic clue, the remaining lesions presented non-characteristic patterns—yellow structureless areas corresponding to the ulceration or polymorphic vascular pattern, known as non-specific sign of malignancy.
Diagnostics 15 02739 g001
Figure 2. The histopathological evaluation showed typical BCC features in all lesions. Two representative images illustrate multifocal aggregation with noduloinfiltrative (A) and nodular superficial (B) growth patterns. One nodular tumor also exhibited a discrete cystic arrangement (B).
Figure 2. The histopathological evaluation showed typical BCC features in all lesions. Two representative images illustrate multifocal aggregation with noduloinfiltrative (A) and nodular superficial (B) growth patterns. One nodular tumor also exhibited a discrete cystic arrangement (B).
Diagnostics 15 02739 g002
Basal cell carcinoma is the most common skin cancer, affecting mostly older individuals with lighter skin phototypes and a history of sun exposure. Such a presentation of multiple, segmental, non-syndromic BCCs seems to be rare, with scarce representation in the literature (Supplementary Table S1) [2,3,4,5,6,7,8,9,10,11]. None of the previously reported cases concerned lesions located exclusively on the arm. The lesions in this patient were classified as segmental due to their linear arrangement along a defined area of the left arm, suggesting a pattern that is compatible with cutaneous mosaicism. All cases included in Supplementary Table S1 similarly involved lesions restricted to one side of the body and were also classified as segmental. Although agminated basal cell carcinomas may appear as clustered lesions in photodamaged skin, the observed linear and unilateral distribution in this case supports a segmental pattern. In the literature, agminated BCC refers to localized clusters of tumors without a clear segmental or blaschkoid distribution [12,13]. This distinction is important to differentiate mosaicism-related segmental BCCs from simple agminated clustering. The etiopathogenesis of this entity remains to be unclear, but it was postulated that it may be caused by a post-zygotic mutation [4]. Although we did not perform gene or protein expression analyses in this case, rare reports have described associations of multiple non-syndromic BCCs with germline or somatic alterations in PTCH1, BAP1, or MUTYH. Given the very limited evidence, further molecular studies are needed to clarify the potential genetic basis of such cases [14,15,16].
Despite several clinicopathological subtypes, due to its distinct clinical and dermoscopic features, in most cases, the diagnosis of BCC does not pose difficulties [1,2]. Some cases of BCC may be difficult to diagnose clinically—i.e., BCC arising on the anterior surface of the lower legs presenting with polymorphic vascular pattern, totally ulcerated BCC with an unknown history of growth, or morpheaform BCC with discrete clinical and dermoscopic features. Another clinical form that is difficult to diagnose without histopathological assessment may be agminated/segmental BCC with equivocal dermoscopic features.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/diagnostics15212739/s1, Table S1. Documented Cases of Multiple, Segmental, Non-Syndromic Basal Cell Carcinoma (BCC).

Author Contributions

Conceptualization, data curation, writing—original draft preparation, M.S. (Martyna Sławińska); writing—review & editing, B.Z.; histopathological figures preparation & review, W.B.; review, investigation & supervision, M.S. (Michał Sobjanek). All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Patient consent was waived, as all patient details have been fully anonymized in accordance with ethical standards, and no identifiable information is included.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Lallas, A.; Apalla, Z.; Argenziano, G.; Longo, C.; Moscarella, E.; Specchio, F.; Raucci, M.; Zalaudek, I. The dermatoscopic universe of basal cell carcinoma. Dermatol. Pract. Concept. 2014, 4, 11–24. [Google Scholar] [CrossRef] [PubMed]
  2. Krajewski, P.; Chlebicka, I.; Hryncewicz-Gwóźdź, A.; Szepietowski, J.C. Non-syndromic Unilateral Basal Cell Carcinomas: A Case Report and Literature Review. Acta Derm. Venereol. 2020, 100, adv00101. [Google Scholar] [CrossRef] [PubMed]
  3. Moulin, G.; Guillaud, V.; Ferrier, E.; Marcellin, X. Unilateral basal cell epitheliomatosis. Ann. Dermatol. Venereol. 1988, 115, 1188–1190. [Google Scholar] [PubMed]
  4. Bouscarat, F.; Avril, M.F.; Prade, M.; Aurias, A.; Guillaume, J.C. Unilateral basal cell epitheliomatosis. Ann. Dermatol. Venereol. 1990, 117, 864–866. [Google Scholar] [PubMed]
  5. Guarneri, B.; Borgia, F.; Cannavò, S.P.; Vaccaro, M.; Happle, R. Multiple familial basal cell carcinomas including a case of segmental manifestation. Dermatology 2000, 200, 299–302. [Google Scholar] [CrossRef] [PubMed]
  6. Weiss, J.; Van Driessche, F.; Wei, E.X.; Shabbir, A. Resident Rounds: Part III—Case Report: A Non-Syndromic Case of Multiple Unilateral Nodular and Pigmented Basal Cell Carcinomas. J. Drugs Dermatol. 2015, 14, 641–642. [Google Scholar] [PubMed]
  7. Yoshikawa, Y.; Takahata, Y.; Ichimiya, M.; Hamamoto, Y.; Muto, M. A case of multiple unilateral localized basal cell carcinomas. J. Dermatol. 2005, 32, 66–68. [Google Scholar] [CrossRef] [PubMed]
  8. Lane, J.E.; Allen, J.H.; Lane, T.N.; Lesher, J.L. Unilateral basal cell carcinomas: An unusual entity treated with photodynamic therapy. J. Cutan. Med. Surg. 2005, 9, 336–340. [Google Scholar] [CrossRef] [PubMed]
  9. Kelly, S.C.; Ermolovich, T.; Purcell, S.M. Nonsyndromic segmental multiple infundibulocystic basal cell carcinomas in an adolescent female. Dermatol. Surg. 2006, 32, 1202–1208, Erratum in Dermatol. Surg. 2006, 32, 1308. [Google Scholar] [CrossRef] [PubMed]
  10. Al Aboud, A.; Hakim, M.; Aljohani, F.; Alehibi, I.; Alotaibi, H.; Bindogji, Y.; Al Zaidi, R.; Alehibi, T.; Almalki, A. Multiple, non-syndromic BCCs involving a hypopigmented patch. Our Dermatol. Online 2022, 13, e58. [Google Scholar] [CrossRef]
  11. Plachouri, K.M.; Mulita, F.; Georgiou, S.; Spiliopoulos, T. Unexpected case of non-syndromic neighbouring basal cell carcinomas. BMJ Case Rep. 2020, 13, e240037. [Google Scholar] [CrossRef] [PubMed]
  12. Shin, J.; Kim, Y.C. Multiple agminated acquired melanocytic nevi. Ann. Dermatol. 2013, 25, 251–252. [Google Scholar] [CrossRef] [PubMed]
  13. Happle, R. Segmental lesions are not always agminated. Arch. Dermatol. 2002, 138, 838. [Google Scholar] [CrossRef] [PubMed]
  14. Saeidian, A.H.; Cohen-Nowak, A.; O’Donnell, M.; Shalabi, D.; McGuinn, K.P.; Youssefian, L.; Vahidnezhad, H.; Niaziorimi, F.; Dasgeb, B.; Kasper, D.A.; et al. Linear basal cell nevus with a novel mosaic PTCH1 mutation. Exp. Dermatol. 2020, 29, 531–534. [Google Scholar] [CrossRef] [PubMed]
  15. de la Fouchardière, A.; Cabaret, O.; Savin, L.; Combemale, P.; Schvartz, H.; Penet, C.; Bonadona, V.; Soufir, N.; Paillerets, B.B. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin. Genet. 2015, 88, 273–277. [Google Scholar] [CrossRef] [PubMed]
  16. Madden, C.; D’Angelo, J.; Blackcloud, P. A case of multiple basal cell carcinomas in a patient with MUTYH gene mutation. JAAD Case Rep. 2025, 59, 85–86. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sławińska, M.; Zagórska, B.; Biernat, W.; Sobjanek, M. Multiple, Segmental, Non-Syndromic Basal Cell Carcinomas—Clinical, Dermoscopic and Histopathological Features. Diagnostics 2025, 15, 2739. https://doi.org/10.3390/diagnostics15212739

AMA Style

Sławińska M, Zagórska B, Biernat W, Sobjanek M. Multiple, Segmental, Non-Syndromic Basal Cell Carcinomas—Clinical, Dermoscopic and Histopathological Features. Diagnostics. 2025; 15(21):2739. https://doi.org/10.3390/diagnostics15212739

Chicago/Turabian Style

Sławińska, Martyna, Beata Zagórska, Wojciech Biernat, and Michał Sobjanek. 2025. "Multiple, Segmental, Non-Syndromic Basal Cell Carcinomas—Clinical, Dermoscopic and Histopathological Features" Diagnostics 15, no. 21: 2739. https://doi.org/10.3390/diagnostics15212739

APA Style

Sławińska, M., Zagórska, B., Biernat, W., & Sobjanek, M. (2025). Multiple, Segmental, Non-Syndromic Basal Cell Carcinomas—Clinical, Dermoscopic and Histopathological Features. Diagnostics, 15(21), 2739. https://doi.org/10.3390/diagnostics15212739

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop